| Overall cohorts |  | Matched cohorts | ||||||
---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Â | Univariate analysis | Multivariate analysis | |||||
HR (95% CI) | P value | HR (95% CI) | P value | Â | HR (95% CI) | P value | HR (95% CI) | P value | |
Age, (years) | 1.02 (0.98–1.06) | 0.447 |  |  |  | 1.05 (0.97–1.12) | 0.220 |  |  |
Male | 1.01 (0.45–2.31) | 0.974 |  |  |  | 0.35 (0.09–1.32) | 0.120 | 0.48 (0.11–2.07) | 0.327 |
Body mass index, (kg/m2) | 0.96 (0.87–1.05) | 0.335 |  |  |  | 0.85 (0.70–1.02) | 0.075 | 0.88 (0.72–1.07) | 0.206 |
Hypertension | 0.64 (0.30–1.38) | 0.255 |  |  |  | 1.10 (0.36–3.33) | 0.866 |  |  |
Diabetes mellitus | 0.75 (0.35–1.58) | 0.447 |  |  |  | 0.21 (0.04–1.01) | 0.051 | 0.43 (0.07–2.64) | 0.362 |
Hyperlipidemia | 0.67 (0.30–1.49) | 0.327 |  |  |  | 1.03 (0.22–4.80) | 0.970 |  |  |
Coronary artery disease | 1.41 (0.55–3.58) | 0.476 |  |  |  | 1.05 (0.31–3.50) | 0.939 |  |  |
Heart failure history | 0.96 (0.39–2.40) | 0.934 |  |  |  | 1.22 (0.26–5.78) | 0.802 |  |  |
Atrial fibrillation | 0.54 (0.26–1.15) | 0.112 | 0.60 (0.27–1.31) | 0.198 |  | 0.76 (0.25–2.35) | 0.637 |  |  |
Cerebrovascular accident | 1.36 (0.54–3.42) | 0.514 |  |  |  | 0.96 (0.21–4.45) | 0.954 |  |  |
Chronic kidney disease | 1.88 (0.77–4.58) | 0.165 | 1.56 (0.62–3.94) | 0.343 |  | 1.65 (0.52–5.23) | 0.397 |  |  |
End-stage renal disease | 1.32 (0.17–9.97) | 0.789 |  |  |  | N/A | N/A |  |  |
Anemia | 1.49 (0.62–3.58) | 0.378 |  |  |  | 0.82 (0.25–2.70) | 0.750 |  |  |
Intravenous temporary pacemaker | 1.42 (0.58–3.50) | 0.441 |  |  |  | 0.69 (0.18–2.59) | 0.580 |  |  |
Complex procedure | 1.07 (0.47–2.45) | 0.868 |  |  |  | 2.24 (0.62–8.12) | 0.219 |  |  |
Pocket hematoma | 1.30 (0.45–3.78) | 0.632 |  |  |  | 0.75 (0.16–3.60) | 0.723 |  |  |